Related Experiment Video
Updated: Feb 2, 2026

Combining Wet and Dry Lab Techniques to Guide the Crystallization of Large Coiled-coil Containing Proteins
Published on: January 6, 2017
Virus study for continuous low pH viral inactivation inside a coiled flow inverter
Laura David1, Benjamin Maiser2, Martin Lobedann1
1Invite GmbH, Biotech, Leverkusen, Germany.
Continuous low pH viral inactivation using a coiled flow inverter (CFI) achieved significant viral reduction (>4 log10) in monoclonal antibody production. Batch and continuous processes demonstrated comparable inactivation times, validating the CFI for scalable viral clearance.
Area of Science:
- Biopharmaceutical Manufacturing
- Viral Clearance
- Process Engineering
Background:
- Continuous processing is increasingly important for monoclonal antibody (mAb) production.
- Low pH viral inactivation is a standard step in mAb manufacturing.
- The coiled flow inverter (CFI) enables continuous low pH viral inactivation, but experimental validation is lacking.
Purpose of the Study:
- To develop and execute a virus study for continuous low pH viral inactivation using a CFI.
- To validate the effectiveness of the CFI for viral clearance in mAb production.
- To demonstrate the adaptability of the concept for other continuous viral clearance steps.
Main Methods:
- Development of a technical rationale for experimental setup, spiking, and sampling.
- Execution of a virus study using xenotropic murine leukemia virus.
- Testing two protein A chromatography setups at different pH levels and comparing with a batch experiment.
Main Results:
- Sufficient low pH viral inactivation (decadic logarithm reduction value >4) was achieved in all tested conditions.
- Complete viral inactivation occurred within 14.5 minutes for both continuous and batch experiments.
- The CFI demonstrated effective viral clearance, comparable to batch processes.
Conclusions:
- The study presents a successful virus study concept and experiment for continuous viral inactivation using a CFI.
- The CFI effectively inactivates viruses, supporting its use in continuous biopharmaceutical manufacturing.
- Transferability of batch results to continuous processes is feasible due to the CFI's plug-flow characteristics.
Related Concept Videos
X-Inactivation
Inverting and Non-inverting OpAmps
Viral Recombination
What are Viruses?
Viral Structure
Activation and Inactivation of G Proteins

